| Thomas Allen Krebs, MD | |
|
412 W Market St, Middleburg, PA 17842-1076 | |
| (570) 837-6163 | |
| (570) 837-7224 |
| Full Name | Thomas Allen Krebs |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 412 W Market St, Middleburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972522373 | NPI | - | NPPES |
| 4242799 | Other | PA | BLUE SHIELD |
| 01803702 | Other | PA | KEYSTONE |
| 6149C3AF | Other | PA | GEISINGER |
| 01803702 | Other | PA | BLUE CROSS |
| 118438706 | Other | PA | DEPARTMENT OF LABOR |
| P00097473 | Other | PA | RAILROAD MEDICARE |
| 232809429 | Other | PA | TRICARE |
| 0011713700003 | Medicaid | PA | |
| E52788 | Other | PA | HEALTH AMERICA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD040846E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Evangelical Community Hospital | Lewisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evangelical Medical Services Organization | 9133033087 | 229 |
News Archive
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses the importance of faith-based organizations in battling malaria in this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
› Verified 8 days ago
| Entity Name | Evangelical Medical Services Organization |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295834984 PECOS PAC ID: 9133033087 Enrollment ID: O20040310000212 |
News Archive
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses the importance of faith-based organizations in battling malaria in this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Allen Krebs, MD 1 Hospital Dr, Suite 306, Lewisburg, PA 17837-9350 Ph: (570) 522-4110 | Thomas Allen Krebs, MD 412 W Market St, Middleburg, PA 17842-1076 Ph: (570) 837-6163 |
News Archive
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses the importance of faith-based organizations in battling malaria in this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
› Verified 8 days ago
Chris James Darrup, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Dock Hill Rd, Middleburg, PA 17842 Phone: 570-837-5889 Fax: 570-837-6600 | |
Susan E Dock, CRNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 412 W Market St, Middleburg, PA 17842 Phone: 570-837-6163 Fax: 570-837-7224 |